Day: June 18, 2020

AS Tallinna Sadam invites interested parties to participate in a webinar tomorrow, 19.06.2020 at 10.00 (EET), where Chairman of the Supervisory Board Aare Tark, Chairman of the Management Board Valdo Kalm and Chairman of the Nomination Committee Veiko Tali will present the content of draft resolutions and answer questions before the voting period starts. In addition, the voting process and possibilities are clarified. The webinar will be held in Estonian.Anyone can take part in the webinar via the Port of Tallinn’s youtube channel. Questions can be asked from the speakers by sending them to the e-mail investor@ts.ee in advance at the latest by beginning of the webinar or during the webinar in writing via the slido application, the link to which can be found in the comments section of the webinar video.Voting of shareholders’...

AS Tallinna Sadam kutsub huvilisi osalema homme, 19.06.2020 kell 10.00 (EET) toimuval veebiseminaril, kus nõukogu esimees Aare Tark, juhatuse esimees Valdo Kalm ja nimetamiskomitee esimees Veiko Tali tutvustavad enne hääletusperioodi algust aktsionäride üldkoosoleku otsuste eelnõude sisu ning vastavad küsimustele. Lisaks selgitatakse aktsionäride otsuste hääletamise protsessi ja võimalusi. Veebiseminar toimub eesti keeles.Veebiseminarist võivad Tallinna Sadama youtube’i kanali kaudu osa võtta kõik soovijad. Esinejatele saab esitada küsimusi, saates need eelnevalt e-mailile investor@ts.ee hiljemalt seminari alguseks või veebiseminari ajal kirjalikult läbi slido rakenduse, mille link on leitav veebiseminari video juures.Aktsionäride otsuste hääletamine toimub perioodil 22.06-29.06.2020, hääleõiguslike aktsionäride nimekiri fikseeritakse...

MANITOWOC, Wis., June 18, 2020 (GLOBE NEWSWIRE) — Orion Energy Systems, Inc. (NASDAQ: OESX) (Orion Lighting), which enables business to digitize and reduce carbon footprint by providing innovative LED lighting systems and turnkey project implementation including installation and commissioning of fixtures, controls and IoT systems, ongoing system maintenance and program management, today announced the receipt of an approximate $3.1 million award related to the LED lighting retrofit of a U.S. government facility.Orion will install LED lighting systems in a large government facility in Nevada. The lighting retrofit project is expected to commence in Orion’s fiscal 2021 second quarter and be completed during Orion’s fiscal 2022. Orion will replace legacy T5, T8, compact fluorescent and high-intensity discharge (HID) lighting systems...

SOUTH ORANGE, NJ, June 18, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Nephros, Inc.(Nasdaq:NEPH), a commercial-stage company that develops and sells high performance water purification products and pathogen detection systems to the medical and commercial markets, today announced that it is set to join the Russell Microcap® Index at the conclusion of the 2020 Russell indexes annual reconstitution, effective after the US market opens on June 29, according to a preliminary list of additions posted June 5.Membership in the Russell Microcap® Index, which remains in place for one year, means automatic inclusion in the appropriate growth and value style indexes. FTSE Russell determines membership for its Russell indexes primarily by objective, market-capitalization rankings, and style attributes.“Recognition from the Russell Microcap...

PALO ALTO, Calif., June 18, 2020 (GLOBE NEWSWIRE) — BridgeBio Pharma, Inc. (NASDAQ: BBIO), a clinical-stage biopharmaceutical company focused on genetic diseases, today announced that it has entered into a collaboration agreement with Johns Hopkins University to support the translation of academic innovations in genetically driven diseases with a goal of clinical development and potential commercialization to reach patients in need.“We are privileged to establish a framework for collaboration with Johns Hopkins University, an institution that has pioneered our understanding of Mendelian disease. Our hope is that this relationship will allow us to build on the significant advances being made in Johns Hopkins’ labs and support work to translate them as quickly and as safely as possible into meaningful medicines for patients in need,”...

PEMBROKE, Bermuda, June 18, 2020 (GLOBE NEWSWIRE) — Altera Infrastructure GP L.L.C. (ALIN GP), the general partner of Altera Infrastructure L.P. (Altera Infrastructure or the Partnership), announced the following change to its Board of Directors (the Board), which was first indicated on January 23, 2020:Kenneth Hvid, Board member and President & Chief Executive Officer of Teekay Corporation, has retired from the Board, effective June 17, 2020.“On behalf of the Board and leadership team, I want to thank Kenneth for his dedicated service, and his many contributions, during his tenure on the Board. Kenneth’s support has been invaluable during the transition to Brookfield’s ownership of the Partnership. We will miss his wise counsel, going forward,” commented Bill Utt, Chairman of the Board.About Altera InfrastructureAltera Infrastructure...

Reopened 593 boutiques as of June 12, 2020First quarter 2020 net sales decreased 50% to $43.8 millionDelays filing of Quarterly Report on Form 10-QHOUSTON, June 18, 2020 (GLOBE NEWSWIRE) — Francesca’s Holdings Corporation (Nasdaq: FRAN) today provides an update on its COVID-19 response and reports select preliminary financial results for the first quarter ended May 2, 2020.  These preliminary results do not include the impact of non-cash impairment charges of long-lived assets, including the related income tax effect, which are expected to have a material impact on the Company’s reported results.Mr. Andrew Clarke, President and CEO, stated, “While we continue to navigate through this difficult period, we are highly encouraged to see bright spots in our business driven by the new strategies that we have been testing and scaling.  We...

REDWOOD CITY, Calif., June 18, 2020 (GLOBE NEWSWIRE) — Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company focused on developing targeted therapies to inhibit frontier cancer targets, today announced the appointments of Eric T. Schmidt, Ph.D., and Peter Svennilson to its board of directors. Dr. Schmidt and Mr. Svennilson are widely respected executives with extensive Wall Street and financial markets experience in the biopharmaceutical industry. Mr. Svennilson was appointed to fill the vacancy created by the resignation of Larry Lasky, Ph.D., who stepped down from the board of directors and will continue supporting the company as a scientific advisor.“Eric and Peter will each strengthen our board’s financial expertise as Revolution Medicines continues maturing as a public company. In particular, Eric brings...

NEW YORK and TORONTO, June 18, 2020 (GLOBE NEWSWIRE) — NexTech AR Solutions (the “Company” or “NexTech”) (OTCQB: NEXCF) (CSE: NTAR) (FSE: N29), an emerging leader in augmented reality for eCommerce, AR learning applications, and video conferencing events is pleased to announce that it has signed a partner supplier agreement with BDA, LLC.BDA Sports will be using the InfernoAR virtual event platform for their signature annual Think Tank 2020 program for teams in NHL, NBA,  MLB, and NFL.BDA. LLC supports high-profile global brands such as Coca-Cola, Sony, AT&T, NFL, Ford, Starbucks, GE, Kellogg’s, HBO and many more by creating high-quality custom merchandise, through e-commerce, and omni-channel programs with integrated marketing campaigns that connect and engage their customers, B2B partners and employees will work under this...

SAN DIEGO, June 18, 2020 (GLOBE NEWSWIRE) — ImprimisRx, the nation’s leading ophthalmic-focused outsourcing facility and pharmaceutical compounding business, a wholly-owned subsidiary of Harrow Health, Inc. (NASDAQ: HROW), today announced its Klarity-C preservative-free formulation (0.1% cyclosporine emulsion) may now be prescribed by Florida’s nearly 2,000 optometrists¹ as a result of the Florida Board of Optometry’s recent additions to its Formulary of Topical Ocular Pharmaceutical Agents. Klarity-C, which has been prescribed for thousands of Americans in all 50 states, was recently recognized at a Best of Saturday Sessions presentation at the 2020 ASCRS Annual Meeting in a presentation entitled “Efficacy of Topical 0.1% Cyclosporine in Chondroitin Sulfate Ophthalmic Emulsion in Patients with Dry Eye” (click here to view the abstract)....